Promega, CDI Collaborate on Stem Cell-Based Drug Toxicity Assays

Cellular Dynamics International and Promega are embarking on a research collaboration to validate stem cell-based assays that can be used during drug development.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories